Methylphenidate for depression in hospice practice: A case series

Jade Homsi, Declan Walsh, Kristine A. Nelson, Susan Legrand, Mellar Davis

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Psychostimulants such as methylphenidate have been used for depression in cancer patients. We report the successful use of methylphenidate to treat depression in 10 consecutive patients with advanced cancer. A rapid onset of effect was noted. Appetite, concentration, fatigue, and sedation also improved in some persons. No severe side effects were noted.

Original languageEnglish (US)
Pages (from-to)393-398
Number of pages6
JournalAmerican Journal of Hospice and Palliative Medicine
Issue number6
StatePublished - Nov 2000


  • cancer
  • depression
  • methylphenidate
  • psychostimulant
  • symptom management

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Methylphenidate for depression in hospice practice: A case series'. Together they form a unique fingerprint.

Cite this